Showing results (61-70 of 98) with videos related to
Sort By:
Pageof 10
Nature Communications|August 28, 2014
Recurrent CDC25C mutations drive malignant transformation in FPD/AMLAkihide Yoshimi, Takashi Toya, Masahito Kawazu, et al.HLA|June 5, 2024
Allelic loss of HLA class I facilitates evasion from immune surveillance in cervical intraepithelial neoplasiaKatsushige Kawase, Ayumi Taguchi, Aya Ishizaka, et al.NPJ Precision Oncology|December 9, 2023
Promoter swapping of truncated PDGFRB drives Ph-like acute lymphoblastic leukemiaBunpei Miyazaki, Toshihide Ueno, Masanaka Sugiyama, et al.Cancer Science|July 6, 2017
Inactivating mutations and hypermethylation of the NKX2-1/TTF-1 gene in non-terminal respiratory unit-type lung adenocarcinomasDaisuke Matsubara, Manabu Soda, Taichiro Yoshimoto, et al.Cancer Research|July 3, 2008
Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancerYoung Lim Choi, Kengo Takeuchi, Manabu Soda, et al.NPJ Precision Oncology|June 23, 2021
Comprehensive molecular profiling of pulmonary pleomorphic carcinomaMasaaki Nagano, Shinji Kohsaka, Takuo Hayashi, et al.NPJ Precision Oncology|May 24, 2024
A molecular glue RBM39-degrader induces synthetic lethality in cancer cells with homologous recombination repair deficiencyShinji Kohsaka, Shigehiro Yagishita, Yukina Shirai, et al.Cancer Discovery|November 20, 2025
Spatial multiomic analyses reveal carcinogenic pathways in end-stage renal diseaseJun Takahashi, Yosuke Tanaka, Yusuke Sato, et al.Cancer Discovery|June 27, 2023
Clinical Activity and Exploratory Resistance Mechanism of Milademetan, an MDM2 Inhibitor, in Intimal Sarcoma with MDM2 Amplification: An Open-Label Phase Ib/II StudyTakafumi Koyama, Toshio Shimizu, Yuki Kojima, et al.Clinical Orthopaedics and Related Research|November 16, 2020
Identification of a Novel MAN1A1-ROS1 Fusion Gene Through mRNA-based Screening for Tyrosine Kinase Gene Aberrations in a Patient with LeiomyosarcomaYoshiyuki Suehara, Shinji Kohsaka, Takuo Hayashi, et al.Pageof 10